Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hematological malignancy manifesting as ascites.

Konstantinos N Lazaridis1, Susan C Abraham, Patrick S Kamath

  • 1Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.

Nature Clinical Practice. Gastroenterology & Hepatology
|November 3, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gallbladder neoplasia is associated with a higher incidence of cholangiocarcinoma in patients with primary sclerosing cholangitis.

Canadian liver journal·2026
Same author

Association of a Polygenic Risk Score with Diagnosis and Outcomes in Idiopathic Pulmonary Fibrosis.

American journal of respiratory and critical care medicine·2026
Same author

Patient Perspectives and Demographic Factors Influencing Non-Participation in a Large Genomics Study.

Mayo Clinic proceedings. Innovations, quality & outcomes·2026
Same author

Oral Vancomycin Is an Effective Therapy in Adult Patients With Inflammatory Bowel Disease and Primary Sclerosing Cholangitis.

Gastro hep advances·2026
Same author

Vitamin B6 predicts poor outcomes in geographically distinct populations with primary sclerosing cholangitis.

Journal of hepatology·2026
Same author

Compositional and functional differences of gut microbiome and metabolome inform pathogenesis of cholestatic liver disease.

Gut microbes·2026

A patient with splenic lymphoma experienced severe ascites due to portal hypertension. Treatment involved chemotherapy and other interventions after splenectomy was declined.

Area of Science:

  • Hematology
  • Oncology
  • Gastroenterology

Background:

  • A 63-year-old woman presented with abdominal discomfort and massive splenomegaly.
  • Initial investigations revealed thrombocytopenia, and splenectomy was recommended but declined.

Observation:

  • The patient returned two years later with tense ascites unresponsive to medical management.
  • Diagnostic workup included bone marrow and liver biopsies, imaging, and blood smear analysis.

Findings:

  • Diagnosis of primary splenic lymphoma with hepatic infiltration was confirmed.
  • This infiltration led to portal hypertension and refractory ascites.

Implications:

  • This case highlights the importance of considering splenic lymphoma in patients with unexplained splenomegaly and ascites.

Related Experiment Videos

  • Multimodal treatment, including chemotherapy, is crucial for managing advanced splenic lymphoma with complications like portal hypertension.